60 DEGREES PHARMACEUTICALS, INC. — Form 8-K
Filed November 20, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
On 2026-11-19, 60 Degrees Pharmaceuticals received notice of failure to satisfy continued listing standards (Item 3.01). The specific listing rule violation, cure period, and any transfer of listing details are not disclosed in the filing header or accessible document summary provided. The company's market capitalization is approximately $3.3M.
Why this rating
Delisting is existential threat for $3.3M company; loss of exchange listing severely impairs capital access, trading liquidity, and investor confidence.
Extracted items
- 3.01 delisting notice
- 7.01 Reg FD disclosure
- 8.01 other event
Price action (we called it negative)
at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from November 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.